Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results

NEXT STORY
Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil
PREV STORY
Global Cell Analysis Instruments Market (2020 to 2025) – Growth, Trends, and Forecasts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaccitech Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

author_avatar
NASDAQ Market News

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

author_avatar
NASDAQ Market News